Scarica l'app Stockscreener
34.48
0.43%
-0.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EXEL Giù?
Forum
Previsione
Precedente Chiudi:
$34.65
Aprire:
$34.75
Volume 24 ore:
191.19K
Relative Volume:
0.10
Capitalizzazione di mercato:
$9.84B
Reddito:
$2.08B
Utile/perdita netta:
$466.92M
Rapporto P/E:
121.71
EPS:
0.2833
Flusso di cassa netto:
$404.94M
1 W Prestazione:
-1.57%
1M Prestazione:
+20.38%
6M Prestazione:
+64.13%
1 anno Prestazione:
+62.58%
Intervallo 1D:
$34.43
$34.91
Intervallo di 1 settimana:
$33.82
$35.13
Portata 52W:
$19.20
$36.60
Exelixis Inc Stock (EXEL) Company Profile
Nome
Exelixis Inc
Settore
Industria
Telefono
(650) 837-7000
Indirizzo
1851 HARBOR BAY PARKWAY, ALAMEDA, CA
Confronta EXEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| EXEL | 34.48 | 9.84B | 2.08B | 466.92M | 404.94M | 0.2833 |
| VRTX | 447.17 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.51 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.70 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 250.25 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Exelixis Inc Stock (EXEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-19 | Iniziato | BTIG Research | Buy |
| 2023-12-15 | Iniziato | Citigroup | Buy |
| 2023-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-22 | Reiterato | Oppenheimer | Outperform |
| 2023-08-08 | Iniziato | SVB Securities | Market Perform |
| 2023-07-11 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Ripresa | Piper Sandler | Overweight |
| 2023-03-09 | Iniziato | Wells Fargo | Overweight |
| 2023-01-26 | Iniziato | Credit Suisse | Outperform |
| 2022-10-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-06-24 | Iniziato | BMO Capital Markets | Outperform |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-11-03 | Ripresa | Jefferies | Buy |
| 2021-10-07 | Iniziato | Jefferies | Buy |
| 2021-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2021-06-15 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-18 | Ripresa | Goldman | Sell |
| 2021-03-31 | Iniziato | Credit Suisse | Outperform |
| 2021-03-12 | Iniziato | Wolfe Research | Outperform |
| 2020-03-04 | Iniziato | Barclays | Overweight |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-11-13 | Iniziato | BofA/Merrill | Buy |
| 2019-03-18 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2018-09-17 | Iniziato | Goldman | Neutral |
| 2018-09-10 | Iniziato | Morgan Stanley | Underweight |
| 2018-05-11 | Reiterato | Needham | Buy |
| 2017-10-17 | Reiterato | Needham | Buy |
| 2017-10-17 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-10-16 | Reiterato | SunTrust | Buy |
| 2017-09-22 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-09-12 | Reiterato | Needham | Buy |
| 2017-07-14 | Iniziato | SunTrust | Buy |
| 2017-03-31 | Iniziato | Needham | Buy |
| 2017-03-16 | Iniziato | Oppenheimer | Perform |
| 2017-02-28 | Downgrade | Stifel | Buy → Hold |
| 2016-11-03 | Iniziato | Deutsche Bank | Buy |
| 2016-10-10 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2016-09-15 | Reiterato | Stifel | Buy |
Mostra tutto
Exelixis Inc Borsa (EXEL) Ultime notizie
Ontario Teachers Pension Plan Board Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
EULAV Asset Management Sells 45,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Thyroid Cancer Therapeutics Market May See a Big Move| Pfizer, Exelixis, AbbVie - openPR
Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity - Yahoo Finance
Exelixis exec Haley Patrick sells $1.43 million in stock By Investing.com - Investing.com Australia
Exelixis exec Haley Patrick sells $1.43 million in stock - Investing.com
Janney Montgomery Scott LLC Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Exelixis, Inc. (NASDAQ:EXEL) Shares Purchased by Seizert Capital Partners LLC - MarketBeat
1 No-Brainer Stock to Buy With $40 - AOL
Cornercap Investment Counsel Inc. Reduces Stake in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
18,300 Shares in Exelixis, Inc. (NASDAQ:EXEL) Bought by Entropy Technologies LP - MarketBeat
Exelixis, Inc. (NASDAQ:EXEL) Receives $31.44 Consensus Target Price from Analysts - MarketBeat
Principal Financial Group Inc. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Here's Why Exelixis (EXEL) is a Strong Momentum Stock - MSN
CWA Asset Management Group LLC Invests $577,000 in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Here's Why Exelixis (EXEL) is a Strong Value Stock - MSN
What Makes Exelixis (EXEL) a Strong Momentum Stock: Buy Now? - MSN
Here is Why Growth Investors Should Buy Exelixis (EXEL) Now - MSN
Los Angeles Capital Management LLC Has $46.47 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Van ECK Associates Corp Boosts Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Have Insiders Sold Exelixis Shares Recently? - Simply Wall St
Exelixis CSO Aftab Dana sells $3.39 million in stock - Investing.com
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November - BioSpace
Exelixis CSO Aftab Dana sells $3.39 million in stock By Investing.com - Investing.com UK
Exelixis to shed 212K sf of industrial in Alameda - The Real Deal
Robeco Institutional Asset Management B.V. Purchases 350,026 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Exelixis stock soars to 52-week high, reaches $35.76 - Investing.com
Exelixis's SWOT analysis: oncology leader's stock poised for growth By Investing.com - Investing.com Australia
Exelixis EVP sells $1.7 million in stock - Investing.com India
Exelixis EVP sells $1.7 million in stock By Investing.com - Investing.com Canada
Exelixis director George Poste sells $1.02 million in shares - Investing.com India
Exelixis director George Poste sells $1.02 million in shares By Investing.com - Investing.com Canada
Earnings Estimates Rising for Exelixis (EXEL): Will It Gain? - MSN
Exelixis (NASDAQ:EXEL) Sets New 52-Week HighTime to Buy? - MarketBeat
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Capital Management Corp VA - MarketBeat
Exelixis's SWOT analysis: oncology leader's stock poised for growth - Investing.com India
Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook - MSN
Exelixis (EXEL) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
3 Magnificent Stocks Under $100 to Buy in November - The Motley Fool
New York State Teachers Retirement System Purchases 20,008 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Dana Aftab Sells 1,162 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock - MarketBeat
Exelixis cso sells stock worth $36,486 By Investing.com - Investing.com Australia
Exelixis cso sells stock worth $36,486 - Investing.com India
Exelixis (NASDAQ:EXEL) Issues Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Trend Tracker for (EXEL) - Stock Traders Daily
Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Exelixis price target raised to $38 from $33 at Truist - MSN
Stephens Investment Management Group LLC Has $98.78 Million Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine - Seeking Alpha
Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript - Insider Monkey
Exelixis stock hits 52-week high at $31.3 amid robust growth - Investing.com Australia
Exelixis Inc Azioni (EXEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):